<DOC>
	<DOCNO>NCT00199264</DOCNO>
	<brief_summary>To compare therapeutic efficacy 10 mg , 40 mg , 80 mg , 160 mg 320 mg albaconazole , single oral dose , woman affect acute non-complicated vulvovaginitis due Candida spp .</brief_summary>
	<brief_title>Efficacy Vulvovaginitis Candida</brief_title>
	<detailed_description>Multi-center , open-label , randomize study , control fluconazole .</detailed_description>
	<mesh_term>Candidiasis</mesh_term>
	<mesh_term>Vulvovaginitis</mesh_term>
	<criteria>Ambulatory patient 18 year age , vaginal score sum Â³ 2 KOH fresh examination positive yeast ( hypha , pseudohyphae ) . The diagnosis must later confirm positive Candida spp . culture . Patients recurrent disease , prior treatment antifungal agent within last 7 day , immunosuppression , pregnant lactate woman , vulvovaginal disease , systemic disease , hypersensitivity azole derivatives.Number patient : 78 patient include obtain 60 evaluable patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2003</verification_date>
	<keyword>antifungal oral therapy</keyword>
	<keyword>efficacy acute candidiasis vulvaginitis</keyword>
</DOC>